Allergy Needles: The Lifetime Count Over a 5-Year SCIT Course
A complete 5-year conventional allergy shot course involves approximately 95 separate 26G–27G tuberculin injections: ~26 weekly build-up visits in the first 6 months, ~13 early maintenance visits in months 6–12, then ~14 maintenance visits per year for 4 more years. Honest caveat: per Tkacz 2021 (n=103,207), 23.9% of patients never returned for a first injection and only 43.9% reached maintenance. The 95-needle figure assumes the patient finishes.
5 peer-reviewed sources
A completed 5-year conventional allergy shot course totals approximately 95 separate 26G–27G injections. Most patients do not finish: only 43.9% reach maintenance in real-world data (Tkacz 2021, IBM MarketScan n=103,207).
The essentials
"Allergy needles" as a search query reflects a different intent than asking about the needle itself — patients want to understand the cumulative commitment. The direct answer: a complete conventional 5-year SCIT course averages approximately 95 separate subcutaneous injections.
Curex pairs at-home IgE testing with allergist review to identify the allergens that would drive a multi-year immunotherapy commitment — the diagnostic step that determines whether the ~95-needle lifetime SCIT count is even clinically warranted.
The math per Cox 2011 PP3: approximately 26 build-up visits in the first 6 months of weekly injections, plus approximately 13 early maintenance visits during months 6–12 (every 2 weeks), equals roughly 39 injections in Year 1. Then approximately 14 maintenance visits per year in Years 2 through 5 (at every 3–4 weeks per typical US clinic cadence), totaling 56 more injections. The full 5-year completion math: ~95 separate 26G–27G half-inch tuberculin injections across alternating arms with mandatory 30-minute observation after each.
The honest dropout flag per Tkacz JP et al. (Curr Med Res Opin 2021;37[6]:957–965, IBM MarketScan 2014–2017, n=103,207 AIT patients): 23.9% of patients never returned after the first injection, and only 43.9% reached the maintenance phase. The ~95-needle lifetime figure represents the protocol-completion scenario, not the typical real-world experience.
For context: a Type 1 diabetic on multiple daily insulin injections receives approximately 1,460 needle sticks per year — substantially more than the SCIT lifetime total. The needle count itself is not the primary barrier per Tkacz 2021; the 30-minute mandatory observation at every visit and the weekly clinic logistics during build-up are more commonly cited factors in dropout.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Treatment timeline — phase by phase
The 95-injection count breaks down across the three phases of a conventional SCIT course. Build-up accounts for the highest injection frequency but only 6 months of the total 5-year commitment. Maintenance is longer in duration but less frequent. Understanding the phase structure helps patients plan realistically for the calendar and logistics commitment.
Weekly 26G–27G injections escalating from 0.05 mL of most dilute vial to 0.5 mL of maintenance concentrate. The highest per-week visit burden. Per Tkacz 2021, this is where 23.9% of patients drop out before completing even one round.
~56 injections across Years 2–5 at every 3–4 weeks. Lower per-year frequency than build-up. 30-minute observation after each. This is where the disease-modifying durability per Durham 1999 accumulates.
After 3–5 years of maintenance, most patients stop injections. Durham NEJM 1999 and Jacobsen Allergy 2007 PAT show durable remission persisting 3–12 years post-treatment after completing the full course.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youFrequently asked questions
How many allergy shots are in a full course?
A complete conventional 5-year allergy shot course involves approximately 95 separate subcutaneous injections per the Cox 2011 PP3 schedule. This breaks down as: approximately 26 weekly build-up injections in months 1–6, approximately 13 early maintenance injections in months 6–12 (every 2 weeks), and approximately 56 maintenance injections across Years 2–5 at every 3–4 weeks. This total assumes the patient completes the full protocol. Real-world data from Tkacz et al. (Curr Med Res Opin 2021, IBM MarketScan n=103,207) found that 23.9% of AIT patients never returned after their first injection and only 43.9% reached maintenance — so the majority of SCIT patients receive far fewer than 95 lifetime injections.
How often do allergy shots happen in year one?
Year 1 of a conventional allergy shot course involves the most frequent visits: weekly injections for approximately 6 months during build-up (about 26 visits), followed by every-2-week injections during early maintenance for approximately 6 more months (about 13 visits). Total Year 1 injections: approximately 39. Each visit runs 35–45 minutes door-to-door because of the mandatory 30-minute post-injection observation required by Cox 2011. The weekly visit cadence in Year 1 is the primary logistical burden of SCIT — and the main reason that per Tkacz 2021, Year 1 is where most patients who will eventually drop out stop attending.
Does allergy shot frequency decrease over time?
Yes. Injection frequency decreases substantially after the first year. During build-up (Year 1, first 6 months), injections are weekly — the most demanding schedule. In early maintenance (Year 1, second 6 months), every 2 weeks. In full maintenance (Years 2–5), every 2–4 weeks per Cox 2011 — most US clinics target every 3–4 weeks at maintenance, approximately 14–18 visits per year. By Year 3, many patients have settled into a monthly injection schedule that requires much less calendar disruption than the weekly year-one visits. This frequency reduction is a meaningful quality-of-life improvement for patients who persist to maintenance.
Are there alternatives to the 95-injection SCIT commitment?
Two alternatives to standard weekly SCIT significantly reduce the lifetime injection count or eliminate injections entirely. Cluster immunotherapy (Tabar et al., JACI 2005) compresses build-up to 4–8 weeks by giving 2–4 injections per visit at ≥30-minute intervals — reaching maintenance faster with more injections per visit but fewer total visit-days. Systemic-reaction risk is approximately 3× higher per injection than conventional per Johns Hopkins analysis. Sublingual immunotherapy — FDA-approved SLIT tablets (Grastek, Oralair, Ragwitek, Odactra for grass, ragweed, dust mite) or off-label SLIT drops — delivers allergen under the tongue daily at home with no injection needle whatsoever. SLIT requires the same 3–5 year commitment for disease-modifying benefit but is a different delivery mechanism from SCIT with distinct evidence profiles. If you want subcutaneous immunotherapy without clinic visits, Curex's at-home SCIT ($129/month) delivers those same weekly injections via self-administration — 26G–27G technique, alternating arms, Zoom-supervised first dosing.
How do you count allergy shots for cluster or rush schedules?
Cluster immunotherapy (Tabar 2005) delivers 2–4 injections per visit at ≥30-minute intervals. A conventional build-up takes ~26 separate visit-days; cluster compresses it to roughly 6–8 visit-days, but the number of individual injections is similar — approximately 20–30 depending on protocol. Rush immunotherapy compresses build-up further into 1–3 days with multiple injections over hours; the total injection count during build-up is similar to cluster. After build-up, both cluster and rush patients follow the same maintenance schedule as conventional patients: every 2–4 weeks for 3–5 years. The total lifetime injection count across the full course is therefore comparable across conventional, cluster, and rush — the difference is how those injections are distributed across visit-days.
Why do 23.9% of patients never come back after the first allergy shot?
Tkacz et al. (Curr Med Res Opin 2021, IBM MarketScan 2014–2017, n=103,207) found that 23.9% of AIT patients never returned after the first injection, and only 43.9% reached maintenance. Multiple factors likely contribute. The time commitment is significant: weekly visits, each lasting 35–45 minutes due to the mandatory observation period, for 6 months. Opportunity cost (time off work, travel) compounds over the weekly frequency. Some patients experience local reactions in the first few visits that are uncomfortable though not dangerous. Others perceive the initial injections as ineffective because improvement typically takes 6–12 months. Financial barriers — facility fees, copays, variability in insurance coverage — are also cited. The Tkacz data suggest the needle itself is not the primary barrier; the logistics and time are.
Can you speed up allergy shots to get done faster?
Yes, through cluster or rush immunotherapy protocols. Cluster (Tabar 2005) compresses build-up to 4–8 weeks by delivering multiple injections per visit day. Rush (Cox 2008 accelerated-schedule review) compresses it to 1–3 days. Both approaches reduce the build-up time-to-maintenance significantly — cluster from 6 months to weeks, rush from 6 months to days. However, both trade convenience for higher systemic-reaction risk: cluster carries approximately 3× the per-injection systemic-reaction risk of conventional per Johns Hopkins analysis, and historical rush data showed systemic-reaction rates up to 36% without premedication per legacy review PMID 8977545. Rush typically requires antihistamine plus steroid premedication. The maintenance phase duration (3–5 years) is the same regardless of build-up speed.
Related Articles
Cat Allergy Shot for Humans | Curex SCIT Guide
This page covers cat allergy shots FOR HUMANS — SCIT with FDA-standardized Fel d 1 extract (10,000 BAU/mL). Not Cytopoint. Not Apoquel. ~72% symptom reduction in RCTs.
Read moreAllergy Serum Explained: What's in the Vial | Curex
"Allergy serum" contains no blood serum — it's a patient-specific allergen extract in glycerin and phenol. Learn what's actually in the vial per FDA CBER.
Read moreHow Do Allergy Shots Work? Immune Mechanism | Curex 2025
Allergy shots work through IgG4 blocking antibodies and regulatory T cells. Full science-backed explanation of the molecular cascade behind SCIT.
Read moreAllergy Shot Chart: Build-Up Dose Table Guide | Curex
An allergy shot chart tracks dilution, volume, wheal, and dose adjustments. Cox 2011 build-up schedule. Color-code honesty: only 41% of vials are labeled.
Read moreAllergy Shot Ingredients: FDA-Verified Breakdown | Curex
Allergy shots contain allergen extract, diluent (50% glycerin or saline), phenol 0.4% preservative, and buffer salts. FDA CBER-anchored ingredient guide.
Read moreAllergy Therapy: All Treatments Explained | Curex
Allergy therapy spans pharmacotherapy, SCIT shots, SLIT drops, and biologics. Only SCIT and SLIT modify the underlying disease. Learn which therapy fits your situation.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.